Merck has announced that the antagonist of the calcitonin gene-related peptide (CGRP) receptor telcagepant has met the primary end points in two Phase III trials to treat migraine, which is ...

The maximum dose is 75 mg within a 24-hour period. Like the anti-CGRP monoclonal antibodies, gepants were created to target migraine specifically. These medications have been shown to be effective ...

W hen it comes to treating a chronic condition like migraine, Western medicine is the new kid on the block, relatively speaking. After all, the vast majority of today’s pharmace ...

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

However, combining a triptan with an NSAID or acetaminophen was less expensive than other treatments, particularly the CGRP antagonists gepants ($5994) and lasmiditan ($6668). Financial ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO ...

Mounting evidence indicates that calcitonin gene-related peptide (CGRP) has a key role in migraine, but full appreciation of the nature of its involvement has remained elusive, owing in part to a ...